calando


Also found in: Dictionary, Acronyms, Wikipedia.
Related to calando: strepitoso, Morendo, meno mosso
  • adj

Words related to calando

gradually decreasing in tempo and volume

Related Words

References in periodicals archive ?
Calando will receive an upfront payment, milestones and royalties on revenue from this HCV therapeutic, however the financial details of the agreement were not disclosed.
Rossi said, "I am excited to be re-associated with Calando as a consultant since I firmly believe they have a proven and effective targeted siRNA delivery system.
Pursuant a purchase agreement between Arrowhead and Calando, Arrowhead purchased approximately 60 million shares of preferred stock in Calando for $1 million in cash and the cancellation of $8 million in debt owed to Arrowhead by Calando.
Calando continued to enroll patients in its Phase I cancer trial and build relationships with potential partners and acquirers.
Calando has already made her mark in France as she ran a very creditable third to Valentine Waltz and Karmifira in the Dubai Poule d'Essai des Pouliches.
Frankie Dettori rattled up a 13-1 double on Handsome Ridge and Calando, who will join Godolphin's classic assault next year.
Later on the Al Bahathri Gallop, Prix de Diane possible Calando travelled smoothly with Fairy Queen and Pescara.
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that its portfolio companies, Calando Pharmaceuticals, Inc.
Other Godolphin horses who went through their paces included Fa-Eq, who enjoyed an upsides effort with Fly To The Stars, while Xaar and Muhtathir went through a similar workout and Fairy Queen looked good in her spin with Calando.
Currently, Arrowhead is focused primarily on its two majority owned subsidiaries: Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology.
Godolphin trainer Saeed Bin Suroor also has French 1,000 Guineas third Calando and Kilting in the Epsom Classic.
We believe that Calando is well positioned to enable a potentially large and robust RNAi field.
Calando 3rd Group 1 Poule d'Essai France pounds 21,529
Arrowhead Research Corporation (NASDAQ:ARWR) ("the Company") today announced that it has increased its ownership of majority owned subsidiary Calando Pharmaceuticals through the exchange of Calando Series A Preferred Stock for Arrowhead warrants.